Cancer Research Prevention Award  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kircher, M. F.
Right arrow Articles by Josephson, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kircher, M. F.
Right arrow Articles by Josephson, L.
[Cancer Research 63, 8122-8125, December 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation

Moritz F. Kircher, Umar Mahmood, Raymond S. King, Ralph Weissleder and Lee Josephson

Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts

The determination of brain tumor margins both during the presurgical planning phase and during surgical resection has long been a challenging task in the therapy of brain tumor patients. Using a model of gliosarcoma with stably green fluorescence protein-expressing 9L glioma cells, we explored a multimodal (near-infrared fluorescent and magnetic) nanoparticle as a preoperative magnetic resonance imaging contrast agent and intraoperative optical probe. Key features of nanoparticle metabolism, namely intracellular sequestration by microglia and the combined optical and magnetic properties of the probe, allowed delineation of brain tumors both by preoperative magnetic resonance imaging and by intraoperative optical imaging. This prototypical multimodal nanoparticle has unique properties that may allow radiologists and neurosurgeons to see the same probe in the same cells and may offer a new approach for obtaining tumor margins.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. A. Jaffer, P. Libby, and R. Weissleder
Optical and Multimodality Molecular Imaging: Insights Into Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1017 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. E Burdette
In vivo imaging of molecular targets and their function in endocrinology
J. Mol. Endocrinol., June 1, 2008; 40(6): 253 - 261.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper
Molecular Neuroimaging: From Conventional to Emerging Techniques
Radiology, October 1, 2007; 245(1): 21 - 42.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Veiseh, P. Gabikian, S-B. Bahrami, O. Veiseh, M. Zhang, R. C. Hackman, A. C. Ravanpay, M. R. Stroud, Y. Kusuma, S. J. Hansen, et al.
Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci
Cancer Res., July 15, 2007; 67(14): 6882 - 6888.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Sosnovik, M. Nahrendorf, and R. Weissleder
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine
Circulation, April 17, 2007; 115(15): 2076 - 2086.
[Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. L. Rosenthal, B. D. Kulbersh, T. King, T. R. Chaudhuri, and K. R. Zinn
Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts
Mol. Cancer Ther., April 1, 2007; 6(4): 1230 - 1238.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Cengelli, D. Maysinger, F. Tschudi-Monnet, X. Montet, C. Corot, A. Petri-Fink, H. Hofmann, and L. Juillerat-Jeanneret
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 108 - 116.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. A. Butowski, P. K. Sneed, and S. M. Chang
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
J. Clin. Oncol., March 10, 2006; 24(8): 1273 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. D. Doolittle, L. E. Abrey, W. A. Bleyer, S. Brem, T. P. Davis, P. Dore-Duffy, L. R. Drewes, W. A. Hall, J. M. Hoffman, A. Korfel, et al.
New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting
Clin. Cancer Res., January 15, 2005; 11(2): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. P. Basilion
Noninvasive monitoring of cellular movements: the utility of MRI and magnetically labeled cells
Blood, January 1, 2005; 105(1): 7 - 8.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.